EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association between coenzyme Q 10-related genetic polymorphisms and statin-associated myotoxicity in Korean stroke patients

Yoon-A Park, Yoonkyung Chang, Da Hoon Lee, Jung Sun Kim, Minju Park, Seo-A Choi, Tae-Jin Song, Hye Sun Gwak

Frontiers in Pharmacology · 07.05.2024 · 15

DOI: 10.3389/fphar.2024.1358567 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 07.05.2024. Verfasst von Yoon-A Park und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The purpose of this study is to identify the relationship between coenzyme Q 10 (CoQ10)-related gene polymorphisms and statin-related myotoxicity (SRM).

Methods

We retrospectively analyzed prospectively collected samples from February to May 2021. To investigate the association between CoQ10-related genetic factors and SRM, we selected 37 single nucleotide polymorphisms from five genes ( COQ2, COQ3, COQ5, COQ6 , and COQ7 ). The odds ratio (OR) and adjusted OR with 95% confidence intervals (CI) were calculated for univariate and multivariable logistic regression analyses, respectively.

Results

A total of 688 stroke patients were included in the analysis, including 56 SRM cases. In the multivariable analysis, two models were constructed using demographic factors only in model I, and demographic and genetic factors in model II. Compared to other statins, atorvastatin decreased the SRM risk whereas ezetimibe use increased the SRM risk in model I and model II. Patients with COQ2 rs4693075 G allele, COQ3 rs11548336 TT genotype, and COQ5 rs10849757 A allele had a 2.9-fold (95% CI: 1.6–5.3), 1.9-fold (95% CI: 1.1–3.5), and 3.3-fold (95% CI: 1.5–8.3) higher risk of SRM, respectively.

Conclusion

This study could be utilized to develop a personalized medicine strategy in patients treated with statins.

Schlagwörter

Stichwörter der Autor:innen

coenzyme Q 10myotoxicitypharmacogenomicspolymorphismsstatin

Autor:innen und Institutionen

  • College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea.
  • Department of Neurology, Mokdong Hospital, College of Medicine, Ewha Womans University, Seoul, Republic of Korea.
  • Department of Neurology, Seoul Hospital, College of Medicine, Ewha Womans University, Seoul, Republic of Korea.

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Park, Y. A., Chang, Y., Lee, D. H., Kim, J. S., Park, M., Choi, S. A., Song, T. J., & Gwak, H. S. (2024). Association between coenzyme Q 10-related genetic polymorphisms and statin-associated myotoxicity in Korean stroke patients. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1358567

Vancouver

Park YA, Chang Y, Lee DH, Kim JS, Park M, Choi SA, et al. Association between coenzyme Q 10-related genetic polymorphisms and statin-associated myotoxicity in Korean stroke patients. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1358567

BibTeX
@article{Park2024,
  author = {Park, Yoon-A and Chang, Yoonkyung and Lee, Da Hoon and Kim, Jung Sun and Park, Minju and Choi, Seo-A and Song, Tae-Jin and Gwak, Hye Sun},
  title = {Association between coenzyme Q 10-related genetic polymorphisms and statin-associated myotoxicity in Korean stroke patients},
  journal = {Frontiers in Pharmacology},
  year = {2024},
  volume = {15},
  doi = {10.3389/fphar.2024.1358567}
}
Kostenlos starten →